OTCMKTS:AUGX Augmedix (AUGX) Stock Price, News & Analysis → Central Banks Preparing for US Dollar Collapse? (From Behind the Markets) (Ad) Free AUGX Stock Alerts $4.09 +0.05 (+1.24%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$3.93▼$4.1650-Day Range$3.20▼$5.0452-Week Range$1.50▼$6.25Volume228,305 shsAverage Volume389,867 shsMarket Capitalization$169.18 millionP/E RatioN/ADividend YieldN/APrice Target$6.83 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC Filings Get Augmedix alerts: Email Address Augmedix MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside67.1% Upside$6.83 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.48) to ($0.36) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.50 out of 5 stars 3.5 Analyst's Opinion Consensus RatingAugmedix has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $6.83, Augmedix has a forecasted upside of 67.1% from its current price of $4.09.Amount of Analyst CoverageAugmedix has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for AUGX. Previous Next 0.0 Dividend Strength Dividend YieldAugmedix does not currently pay a dividend.Dividend GrowthAugmedix does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AUGX. Previous Next 0.6 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for Augmedix this week, compared to 1 article on an average week.Search Interest8 people have searched for AUGX on MarketBeat in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Augmedix insiders have not sold or bought any company stock.Percentage Held by Insiders10.97% of the stock of Augmedix is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions87.11% of the stock of Augmedix is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Augmedix are expected to grow in the coming year, from ($0.48) to ($0.36) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Augmedix is -7.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Augmedix is -7.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAugmedix has a P/B Ratio of 40.90. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad DTIWarning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…Watch the presentation here About Augmedix Stock (OTCMKTS:AUGX)Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Notes that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, a self-service mobile software application. The company enables clinicians to access its applications through mobile devices, such as smartphones or Google Glass. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.Read More AUGX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AUGX Stock News HeadlinesMarch 26, 2024 | americanbankingnews.comAugmedix (OTCMKTS:AUGX) Trading Up 1%March 19, 2024 | finanznachrichten.deAugmedix Inc: Augmedix Delivers 45% Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023March 29, 2024 | WealthPress (Ad)A lot of people are making this costly mistakeYou may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. March 19, 2024 | markets.businessinsider.comBenchmark Co. Keeps Their Buy Rating on Augmedix (AUGX)March 18, 2024 | investorplace.comAUGX Stock Earnings: Augmedix Beats EPS, Beats Revenue for Q4 2023March 18, 2024 | finance.yahoo.comAugmedix Inc (AUGX) Reports Strong Revenue Growth and Margin Expansion in Q4 and Full Year 2023March 16, 2024 | finance.yahoo.comAUGX Mar 2024 7.500 callMarch 16, 2024 | finance.yahoo.comAUGX Apr 2024 5.000 callMarch 29, 2024 | DTI (Ad)Warning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…March 12, 2024 | finanznachrichten.deAugmedix Inc: Augmedix Announces New Positive Data and Enhancements to Its Ambient AI Product, Augmedix GoFebruary 25, 2024 | edition.cnn.comAugmedix IncFebruary 15, 2024 | bizjournals.comDaily Digest: Cisco releases layoff total; A's in Coliseum extension talksFebruary 13, 2024 | finance.yahoo.comAugmedix Names Tomer Levy as New Senior Vice President of EngineeringJanuary 30, 2024 | markets.businessinsider.comBuy Rating Affirmed for Augmedix Amid Funding Success and Strong Growth ProspectsJanuary 16, 2024 | finance.yahoo.comAugmedix Announces Participation in Maxim Group Virtual Healthcare IT Investor ConferenceJanuary 7, 2024 | benzinga.comAugmedix Stock (NASDAQ:AUGX) Dividends: History, Yield and DatesJanuary 6, 2024 | msn.comAugmedix says Q4 revenue is expected to be about $12.5MDecember 13, 2023 | finance.yahoo.comAugmedix Partners with Google Cloud to Bring Medically-Tuned AI Technology to Ambient DocumentationDecember 9, 2023 | finance.yahoo.comAugmedix, Inc. (NASDAQ:AUGX) has caught the attention of hedge funds investors who hold a sizeable 40% stakeNovember 27, 2023 | msn.comAugmedix (AUGX) Price Target Increased by 7.60% to 7.82November 24, 2023 | uk.finance.yahoo.comAugmedix, Inc. (AUGX)November 16, 2023 | investorplace.comWhy Is Augmedix (AUGX) Stock Down 27% Today?November 15, 2023 | finance.yahoo.comAugmedix Announces Proposed Public Offering of 5,500,000 Shares of Common StockNovember 10, 2023 | finance.yahoo.comHow Much Upside is Left in Augmedix, Inc. (AUGX)? Wall Street Analysts Think 36.67%November 9, 2023 | finance.yahoo.comAnalyst Estimates: Here's What Brokers Think Of Augmedix, Inc. (NASDAQ:AUGX) After Its Third-Quarter ReportNovember 7, 2023 | finance.yahoo.comAugmedix, Inc. (NASDAQ:AUGX) Q3 2023 Earnings Call TranscriptOctober 9, 2023 | finance.yahoo.comGetting In Cheap On Augmedix, Inc. (NASDAQ:AUGX) Might Be DifficultSee More Headlines Receive AUGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Augmedix and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/27/2023Today3/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolOTCMKTS:AUGX CUSIPN/A CIK1769804 Webwww.augmedix.com Phone888-669-4885FaxN/AEmployees1,040Year FoundedN/APrice Target and Rating Average Stock Price Target$6.83 High Stock Price Target$8.00 Low Stock Price Target$6.00 Potential Upside/Downside+67.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.45) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-24,450,000.00 Net Margins-57.70% Pretax Margin-57.23% Return on Equity-980.09% Return on Assets-57.85% Debt Debt-to-Equity Ratio3.74 Current Ratio1.70 Quick Ratio1.70 Sales & Book Value Annual Sales$40.93 million Price / Sales4.13 Cash FlowN/A Price / Cash FlowN/A Book Value$0.10 per share Price / Book40.90Miscellaneous Outstanding Shares41,364,000Free Float36,316,000Market Cap$169.18 million OptionableNot Optionable Beta-0.14 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Emmanuel Krakaris (Age 65)President, CEO, Secretary & Director Comp: $734.33kMr. Ian Shakil (Age 39)Founder, Chief Strategy Officer & Director Ms. Sandra Breber (Age 66)Chief Operating Officer Comp: $446.05kMr. Saurav Chatterjee Ph.D. (Age 52)Chief Technology Officer Comp: $438.05kMr. Paul Louis Ginocchio (Age 54)Chief Financial Officer Todd HolvickHead of Legal & ComplianceLia WallickHead of PeopleDr. Davin Lundquist M.D.Chief Medical OfficerMr. Jonathan Hawkins (Age 54)Chief Revenue Officer Comp: $417.71kMr. Tomer LevySenior Vice President of EngineeringMore ExecutivesKey CompetitorsForianNASDAQ:FORACytoDynOTCMKTS:CYDY10X Capital Venture Acquisition Corp. IIINYSE:VCXBKaryopharm TherapeuticsNASDAQ:KPTIGlobal Cord BloodNYSE:COView All CompetitorsInsidersMargie L TraylorBought 26,530 shares on 6/14/2023Total: $119,650.30 ($4.51/share)View All Insider Transactions AUGX Stock Analysis - Frequently Asked Questions Should I buy or sell Augmedix stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Augmedix in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AUGX shares. View AUGX analyst ratings or view top-rated stocks. What is Augmedix's stock price target for 2024? 3 analysts have issued 1-year target prices for Augmedix's stock. Their AUGX share price targets range from $6.00 to $8.00. On average, they anticipate the company's share price to reach $6.83 in the next twelve months. This suggests a possible upside of 67.1% from the stock's current price. View analysts price targets for AUGX or view top-rated stocks among Wall Street analysts. How have AUGX shares performed in 2024? Augmedix's stock was trading at $5.85 at the start of the year. Since then, AUGX shares have decreased by 30.1% and is now trading at $4.09. View the best growth stocks for 2024 here. How were Augmedix's earnings last quarter? Augmedix, Inc. (OTCMKTS:AUGX) issued its earnings results on Monday, March, 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.16) by $0.01. The company earned $8.75 million during the quarter, compared to analysts' expectations of $8.52 million. Augmedix had a negative trailing twelve-month return on equity of 980.09% and a negative net margin of 57.70%. How do I buy shares of Augmedix? Shares of AUGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:AUGX) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingFed launches fourth dollar overhaulStansberry ResearchThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Augmedix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.